Please assess the completion status of the following clinical trial:

Trial Title: Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and Females 18-65 years old~* VEINES Sym Score less than 75 points~* Varicose Vein clinical classification CEAP 2, 3, 4, or 5~* Incompetence of SFJ associated with incompetence of the GSV or other major accessory vein~* Superficial venous disease manifested by both symptoms and visible varicosities~* Ability to comprehend and sign an informed consent document and completed study questionnaires in English~Exclusion Criteria:~* Incompetence of the SSV which substantially contributes to the filling of visible varicose veins~* Current or previous Deep Vein Thrombosis~* Leg obesity~* Peripheral arterial disease in the leg to be treated~* Reduced mobility~* Planned prolonged travel with limited mobility with in 4 weeks of treatment~* History of pulmonary embolism or stroke~* Major surgery, prolonged hospitalization or pregnancy within 3 months~* Current anticoagulation therapy (within 7 days of enrollment)~* Participation in a clinical study involving a investigational product within 3 months~* Major co-existing disease or clinically significant laboratory abnormalities~* Known allergic response to polidocanol or heparin or severe and/or multiple allergic reactions~* Women of childbearing potential not using effective contraception one month prior to enrollment and/or unwilling to continue while on study~* Pregnant or lactating women~* Current alcohol or drug abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Varisolve (polidocanol endovenous mircofoam)
- 2 (Type: PLACEBO_COMPARATOR): Agitated saline

Based on this trial design, predict the completion outcome and termination type (if applicable).